The Immunomonitoring Laboratory (IML) is a centralized immune monitoring facility that facilitates the translation of basic immune system research findings into the cancer immunotherapy arena, to support ongoing and new clinical cancer immunotherapy trials and to develop novel mechanistic insights into human immune system-cancer interactions. IML provides the means to monitor developing immune responses to […]
